Picture supply: Getty Pictures
The Aviva (LSE: AV) share worth has accomplished what few different FTSE 100 financials have managed during the last 12 months… placed on a little bit of a present.
As someone who holds Authorized & Normal Group, M&G and Phoenix Group Holdings, I discover this moderately annoying. Their shares are all down since I purchased them final 12 months (though their bumper dividends compensate).
Aviva’s the one which bought away however even its shares have plateaued recently, together with the remainder of the FTSE. Not right this moment although.
This FTSE 100 monetary inventory is thrashing its rivals
They’ve jumped 4.66% to this point this morning following a well-received set of Q3 outcomes, which confirmed double-digit development normally insurance coverage premiums, life insurance coverage and retirement gross sales, and even wealth web flows.
Normal insurance coverage premiums climbed 15% over the primary 9 months of the 2024 monetary 12 months to £9.1bn. Safety and well being gross sales leapt 22% to £403m, boosted by April’s acquisition of AIG UK.
Retirement gross sales have been the large winner although, up 67% to £7.3bn. The massive insurers have recognized bulk buy annuities as a large development space, and so it’s proved with Aviva’s revenues virtually doubling to £6.1bn.
Bulk annuities contain taking on an organization’s pension schemes to bear the chance on behalf of administration. It’s given insurers an enormous new market to goal at. There’s loads of competitors with L&G, M&G, Phoenix and others jostling for share, however Aviva’s clearly holding its personal.
Chief govt Amanda Blanc declared Q3 “very strong” and pinned it on Aviva’s constant technique, scale, diversification and monetary energy.
Aviva’s nonetheless forecasting £2bn of working revenue by 2026, up from £1.47bn in 2023. Shareholders ought to get their rewards, with Blanc assured of “growing the dividend” and making “regular and sustainable returns of capital”.
Dividends aren’t assured and Aviva’s haven’t recaptured their pre-pandemic highs, as this chart reveals.
Chart by TradingView
Nevertheless, they’ve nonetheless been climbing steadily and right this moment’s bumper trailing yield of seven.02% is forecast to hit 7.81% in 2024 and eight.39% in 2025.
A excessive fee of dividend earnings and development prospects
Aviva seems to be respectable worth with a trailing price-to-earnings (P/E) ratio of simply 12.6. That’s under the FTSE 100 common of 14.2 instances.
There are downsides although. The massive FTSE 100 financials haven’t provided a lot share worth development for years. Aviva’s up 10.3% over 12 months, and a modest 18.09% over three years. The dividend has to do loads of heavy lifting to maintain shareholders glad.
I anticipated Aviva and the opposite FTSE 100 financials to get a serious increase as central bankers slashed rates of interest. This may make the earnings they pay look much more dazzling relative to financial savings charges and bond yields.
Additionally, I hoped fee cuts would gentle a fireplace beneath their share costs, however with inflation anticipated to stay sticky, I’m not so certain right this moment. So its shares might idle regardless of sturdy gross sales development. Think about in the event that they decelerate?
I’d nonetheless purchase Aviva like a shot however I’m already over-exposed to this sector because of Authorized & Normal, M&G and Phoenix. If I had a time machine I’d fly again and swap the lot of them for Aviva. Alas…
